Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SHR 9549

Next Previous
Drug Profile

SHR 9549

Alternative Names: SHR-9549

Latest Information Update: 19 Sep 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Jiangsu Hengrui Medicine Co.
  • Class Antineoplastics; Small molecules
  • Mechanism of Action Estrogen receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Breast cancer

Most Recent Events

  • 19 Sep 2022 Discontinued - Phase-I for Breast cancer (Late-stage disease, Second-line therapy or greater) in China (PO) (Jiangsu Hengrui Medicine pipeline, September 2022)
  • 28 Feb 2022 No recent reports of development identified for preclinical development in Breast-cancer in China (PO, Tablet)
  • 14 Oct 2019 Jiangsu Hengrui Medicine terminates a phase I trial in Breast cancer (Late-stage disease, Second-line therapy or greater) in China (PO) due to sponsor's R & D Strategy Adjustment (NCT03596658)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top